Pharmacogenetics of pancreatic cancer: from standard chemotherapy to personalized strategies
Conflicts of Interest Disclosure:
The authors declares that there is no conflict of interest.
Article info:
Date submitted: 31.10.2025
Published: 01.11.2025
The author has read and approved the final manuscript.
Peer review info:
"Pharmacogenetics and Pharmacogenomics" thanks the anonymous reviewer(s) for their contribution to the peer review of this work.
Editorial comment:
In case of any discrepancies in a text or the differences in its layout between the pdf-version of an article and its html-version the priority is given to the pdf-version.
About the Author
D. A. Sychev
Russian Federation
Competing Interests:
Дмитрий Алексеевич Сычев - д. м. н., профессор, академик РАН, главный редактор журнала «Фармакогенетика и Фармакогеномика»
For citations:
Sychev D.A.
Pharmacogenetics of pancreatic cancer: from standard chemotherapy to personalized strategies. Pharmacogenetics and Pharmacogenomics. 2025;(2):3-4.
(In Russ.)
Views:
6